First, in heart ischemia, pre-emptive conditioning by HSP22 leads to a new therapeutic strategy for patients under unstable angina and repetitive ischemic episodes or for those who will proceed with revascularization surgery. This evidence concerns the gene HSPB8 and angina pectoris.